Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Curis (CRIS) Research & Development (2016 - 2026)

Curis filings provide 16 years of Research & Development readings, the most recent being $5.8 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 35.05% to $5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 million, a 26.73% decrease, with the full-year FY2025 number at $28.3 million, down 26.73% from a year prior.
  • Research & Development hit $5.8 million in Q4 2025 for Curis, down from $6.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $12.3 million in Q2 2022 to a low of $5.8 million in Q4 2025.
  • Median Research & Development over the past 5 years was $9.4 million (2023), compared with a mean of $9.2 million.
  • Biggest five-year swings in Research & Development: skyrocketed 92.05% in 2021 and later plummeted 35.05% in 2025.
  • Curis' Research & Development stood at $10.8 million in 2021, then dropped by 19.18% to $8.7 million in 2022, then increased by 14.45% to $10.0 million in 2023, then decreased by 10.0% to $9.0 million in 2024, then plummeted by 35.05% to $5.8 million in 2025.
  • The last three reported values for Research & Development were $5.8 million (Q4 2025), $6.4 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.